Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
2.820
-0.180 (-6.00%)
At close: Aug 1, 2025, 4:00 PM
2.830
+0.010 (0.35%)
After-hours: Aug 1, 2025, 4:10 PM EDT
Revance Therapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $68.70 million as of August 1, 2025.
Market Cap
68.70M
Enterprise Value
-83.02M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $68.70M, a decrease of -61.13%. That is a compound annual growth rate of -59.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 73.09M | -70.15% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |